Stocks
USANA Health Sciences (USNA) Debt/EBITDA US GAAP (year values) |
|||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | CAGR 5 years ? | |||
| Debt/EBITDA | -1.15 | -2.11 | -2.58 | -1.44 | -1.76 | -1.90 | |||
| Changes by years, y/y, % | -20% | +83% | +22% | -44% | +22% | +3.9% | |||
USANA Health Sciences. Debt/EBITDA
USANA Health Sciences. Debt/EBITDA, changes, %
USANA Health Sciences (USNA) Debt/EBITDA US GAAP (quarter values) |
||||||||
| FY2025Q1 | FY2025Q2 | FY2025Q3 | FY2025Q4 | FY2026Q1 | LTM ? | |||
| Debt/EBITDA | -1.71 | -1.56 | -1.73 | -1.76 | -1.86 | -1.90 | ||
| Changes by years, y/y, % | -36% | -47% | -47% | +19% | +9% | |||
| Changes by quarters, q/q, % | +16% | -9% | +11% | +2% | +5% | |||
